- Home
- Products
- Customized ADCs
- TMEFF2
- Anti-TMEFF2-Mc-VC-PABC-MMAE ADC
Anti-TMEFF2-Mc-VC-PABC-MMAE ADC (CAT#: ADC-W-437)
This ADC product is comprised of an anti-TMEFF2 monoclonal antibody conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAE binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- TMEFF2
- Alternative Names
- TMEFF2; transmembrane protein with EGF-like and two follistatin-like domains 2; TR; HPP1; TPEF; TMEFF2; CT120.2; tomoregulin-2; TR-2; tomoregulin; transmembrane protein TMEFF2; hyperplastic polyposis protein 1; cancer/testis antigen family 120, member 2;
- Target Entrez Gene ID
- 23671
- Target UniProt ID
- Q9UIK5
- Overview
- TENB2 encodes a putative transmembrane proteoglycan, related to the EGF/heregulin family of growth factors and follistatin, which has been identified through the application of a differential display technique to a xenograft model of prostate cancer.
- Overview
- Anti-TMEFF2 Antibody
- Species Reactivity
- Human
- Name
- MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Description
- Peptide linkers, belonging to Enzymatically cleavable linkers, combine greater systemic stability with rapid enzymatic release of the drug in the target cell. The scission of peptidic bonds relies on lysosomal proteolytic enzymes, which have very low activities in blood due to endogenous inhibitors and the unfavorably high pH value of blood.
- Name
- MMAE (Monomethyl auristatin E)
- Description
- Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD4 (Tregalizumab)-SPDB-DM4 ADC (CAT#: ADC-W-873)
- Anti-CD22-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-2531)
- Anti-FN1 (clone F8)-CemCH2-SH ADC (CAT#: ADC-W-575)
- Anti-Rabies Virus Glycoprotein (Foravirumab)-MC-MMAF ADC (CAT#: ADC-W-1966)
- Anti-Rabies Virus Glycoprotein (Rafivirumab)-SMCC-DM1 ADC (CAT#: ADC-W-1958)
- Anti-CD33 (clone HuM195)-AcBut-Calicheamicin ADC (CAT#: ADC-W-357)
- Anti-MS4A1 (Rituximab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2613)
- Anti-MUC1 (Cantuzumab )-SPDB-DM4 ADC (CAT#: ADC-W-1611)
- Anti-IGHE (Ligelizumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1284)
- Anti-ITGAL (Odulimomab)-MC-MMAF ADC (CAT#: ADC-W-1486)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-437. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
CAT# | Product Name | Linker | Payload |
ADC-W-086 | Anti-TMEFF2-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
ADC-W-441 | Anti-TMEFF2 (clone huPr1)-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
ADC-W-088 | Anti-TMEFF2 (TMEFF2#19)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
ADC-W-087 | Anti-TMEFF2-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
ADC-W-089 | Anti-TMEFF2 (TMEFF2#19)-Mc-VC-PABC-MMAE ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
CAT# | Product Name | Linker | Payload |
ADC-W-611 | Anti-CD72 (10D6.8.1)-Mc-VC-PABC-MMAE ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
ADC-W-506 | Anti-VTCN1 (clone h1D11)-MC-vc-PABC-MMAE ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
ADC-W-451 | Anti-CD70 (clone 1F6)-Mc-VC-PABC-MMAF ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAF (Monomethyl auristatin F) |
ADC-W-455 | Anti-MSLN (clone h7D9.v3)-Mc-VC-PABC-MMAE ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
ADC-W-466 | Anti-MUC16-Mc-VC-PABC-MMAE ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
CAT# | Product Name | Linker | Payload |
ADC-W-465 | Anti-TNFRSF8 (Brentuximab)-VC-PAB-MMAE ADC | VC-PAB (valine-citrulline with PAB) | MMAE (Monomethyl auristatin E) |
ADC-AA-052 | Protein A-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
ADC-AA-048 | Protein G-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
ADC-W-499 | Anti-SLC34A2 (Lifastuzumab)-VC-MMAE ADC | mc-VC-PABC | MMAE (Monomethyl auristatin E) |
ADC-W-462 | Anti-GPNMB-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.